97 related articles for article (PubMed ID: 21156162)
1. Regulation of Na(+)-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein.
Leiprecht N; Munoz C; Alesutan I; Siraskar G; Sopjani M; Föller M; Stubenrauch F; Iftner T; Lang F
Biochem Biophys Res Commun; 2011 Jan; 404(2):695-700. PubMed ID: 21156162
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of the Na(+)-coupled glucose transporter SGLT1 by B-RAF.
Pakladok T; Hosseinzadeh Z; Alesutan I; Lang F
Biochem Biophys Res Commun; 2012 Nov; 427(4):689-93. PubMed ID: 23010278
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of the glucose carrier SGLT1 by JAK2.
Hosseinzadeh Z; Bhavsar SK; Shojaiefard M; Saxena A; Merches K; Sopjani M; Alesutan I; Lang F
Biochem Biophys Res Commun; 2011 May; 408(2):208-13. PubMed ID: 21406183
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of Na(+)-coupled glucose transporter SGLT1 by caveolin-1.
Elvira B; Honisch S; Almilaji A; Pakladok T; Liu G; Shumilina E; Alesutan I; Yang W; Munoz C; Lang F
Biochim Biophys Acta; 2013 Nov; 1828(11):2394-8. PubMed ID: 23774524
[TBL] [Abstract][Full Text] [Related]
5. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
6. Expression of JAK3 Sensitive Na+ Coupled Glucose Carrier SGLT1 in Activated Cytotoxic T Lymphocytes.
Bhavsar SK; Singh Y; Sharma P; Khairnar V; Hosseinzadeh Z; Zhang S; Palmada M; Sabolic I; Koepsell H; Lang KS; Lang PA; Lang F
Cell Physiol Biochem; 2016; 39(3):1209-28. PubMed ID: 27595398
[TBL] [Abstract][Full Text] [Related]
7. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism.
Clere N; Bermont L; Fauconnet S; Lascombe I; Saunier M; Vettoretti L; Plissonnier ML; Mougin C
Exp Cell Res; 2007 Sep; 313(15):3239-50. PubMed ID: 17678892
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of Na+/K+ ATPase activity and Na+ coupled glucose transport by β-catenin.
Sopjani M; Alesutan I; Wilmes J; Dërmaku-Sopjani M; Lam RS; Koutsouki E; Jakupi M; Föller M; Lang F
Biochem Biophys Res Commun; 2010 Nov; 402(3):467-70. PubMed ID: 20951116
[TBL] [Abstract][Full Text] [Related]
10. SPAK-sensitive regulation of glucose transporter SGLT1.
Elvira B; Blecua M; Luo D; Yang W; Shumilina E; Munoz C; Lang F
J Membr Biol; 2014 Nov; 247(11):1191-7. PubMed ID: 25161031
[TBL] [Abstract][Full Text] [Related]
11. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase.
Sopjani M; Bhavsar SK; Fraser S; Kemp BE; Föller M; Lang F
Mol Membr Biol; 2010 Apr; 27(2-3):137-44. PubMed ID: 20334581
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
Koivusalo R; Krausz E; Helenius H; Hietanen S
Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Na-coupled glucose transporter SGLT1 by Tau tubulin kinase 2.
Alesutan I; Sopjani M; Dërmaku-Sopjani M; Munoz C; Voelkl J; Lang F
Cell Physiol Biochem; 2012; 30(2):458-65. PubMed ID: 22814243
[TBL] [Abstract][Full Text] [Related]
15. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
16. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of electrogenic glucose transport by glycogen synthase kinase 3.
Rexhepaj R; Dërmaku-Sopjani M; Gehring EM; Sopjani M; Kempe DS; Föller M; Lang F
Cell Physiol Biochem; 2010; 26(4-5):641-6. PubMed ID: 21063101
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein.
Vogt M; Butz K; Dymalla S; Semzow J; Hoppe-Seyler F
Oncogene; 2006 Jul; 25(29):4009-15. PubMed ID: 16462759
[TBL] [Abstract][Full Text] [Related]
19. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
20. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
